
July 25, 2024
The Directors of eMetals Limited (ASX:EMT)(eMetals)(Company) are pleased advise it has entered into a binding terms sheet (Agreement) with Sifang Mineral Resources Limited (Sifang), a Ugandan incorporated company, and its shareholders (Sifang Shareholders) to acquire an interest in a granted exploration licence (EL00379) located in central Uganda (the Mubende Gold Project) through the purchase 80% of the ordinary shares in Sifang. Sifang is the 100% legal and beneficial owner of the Mubende Gold Project and four exploration license applications located in central Uganda (the Applications).
HIGHLIGHTS
- The granted exploration license EL00379 covers 202 square kilometres in the Mubende region west of Kampala and includes the highly prospective Bukuya prospect.
- The Bukuya prospect is currently being mined by 60-80 artisanal workers over 600 metres of prospective strike and remains open along strike and at depth.
- Rock chip samples taken from a recent site visit to the Bukuya prospect by consultant geologists returned numerous specimens containing visible gold in both ferro-manganese and quartz veins.
- Experienced in-country technical team appointed including Mr Dylan le Roux and Mr Allan Agumya to manage exploration activities.
- Field activities scheduled to commence 05 August 2024.
Commenting on the acquisition Managing Director Mr Mathew Walker stated, “We are delighted to have secured a significant land holding that has prospectivity confirmed by a strong presence of artisanal mining activity. Uganda has a well established gold mining industry and regulatory protocols that add to the appeal of the acquisition. We look forward to the commencement of field activities in the immediate term.”
MUBENDE GOLD PROJECT
The Mubende Gold Project is an extensive landholding of 202 square kilometers that covers a series of metasediments, predominantly characterized by meta-wacke’s and phyllitic slates, with occasional interbedded quartzite units and mafic volcanics. Late-stage granites have intruded the metasediments, mainly in the southern part of the license.

At the Bukuya prospect, wall rock consists of metapelitic units with vertical foliation trending NW in most shafts, turning EW in the northern artisanal shafts. Mineralization appears confined to a deformation zone within the metapelites and hosts three subsets of veins exploited by artisanal workers. The first subset includes quartz veins with hematite mineralization, iron-oxide staining, and goethite/limonite-filled vugs, seen in southern shafts with NW trending foliation. The second subset comprises metallic veins of blueish-grey and black ferro-manganese mineralisation with botryoidal textures and specular hematite, found in northern shafts with EW trending foliation. The third set comprises massive milky white quartz veins.
These veins are described in more detail below.
Type 1 (Iron-rich quartz veins): These are quartz veins that show varying degrees of ferro(-manganese) mineralisation. Mineralisation occurs as hematite (red), specular hematite (dark silver/black), and a lesser degree of manganese (botryoidal, blue-grey to black). Vugs filled with limonitic material is often seen in these veins and is interpreted to represent leached out sulphides. These veins are seen in the SE of the Bukuya site. They are typically decimetre to metre scale and are foliation concordant (vertical to subvertical with dominantly NW trend).
Click here for the full ASX Release
This article includes content from eMetals Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
EMT:AU
INN Article Notification
The Conversation (0)
25 February 2021
eMetals Limited
Building a strong pipeline of mineral projects to drive shareholder value.
Building a strong pipeline of mineral projects to drive shareholder value. Keep Reading...
11h
Ronald-Peter Stoeferle: Gold Price Hasn't Topped, on Track for US$8,900
Ronald-Peter Stoeferle of Incrementum shares takeaways from the latest "In Gold We Trust" report, emphasizing that gold is currently in a bull market consolidation phase.Overall he believes the yellow metal is in the midst of a "golden decade" that will ultimately take it to his price target of... Keep Reading...
16h
Chinese Regulator Delays Zijin Gold’s US$4 Billion Allied Gold Takeover
Beijing’s National Development and Reform Commission (NDRC) has delayed regulatory approval for Zijin Gold International's (HKEX:2259,OTCPL:ZJNGF) US$4 billion acquisition of Allied Gold (TSX:AAUC,NYSE:AAUC), questioning the transaction premium and the political risks of the target's mining... Keep Reading...
29 May
Editor's Picks: Gold, Silver Face Bumpy Week as Prices Drop, Then Rebound
It was a bumpy week for the gold price, which dropped to the US$4,370 per ounce level midway through the period before rebounding back above US$4,500.Silver put on a similar performance, bottoming out at US$72 per ounce.Both precious metals were reacting to a complex array of dynamics, including... Keep Reading...
28 May
Precious Metals News: Gold, Silver and PGM Price Floors Hold Up Against Headwinds
The precious metals complex is proving resilient in the face of intensifying macroeconomic headwinds and ongoing uncertainty over the direction of the conflict in the Middle East. Prices for gold, silver, platinum and palladium fell below key psychological levels this week on the back of hawkish... Keep Reading...
27 May
Stephen Leeb: Gold Price to US$18,000? Here's How it Can Happen
Dr. Stephen Leeb of Leeb Capital Management shares his outlook for gold, explaining how the yellow metal could get to US$18,000 per ounce. "Gold's high point might not ever really be defined, because I think at the end of this period that we're in, you're going to find gold at the center of the... Keep Reading...
Latest News
Interactive Chart
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00






